ARS Pharmaceuticals Inc

SPRYNASDAQ
$5.65
-0.45-7.38%
At close: Aug 13, 5:00 PM EST
$5.65
-0.45-7.38%
Pre-Market: 4:11 AM EST
Earnings: Q2 2026 Earnings were released on Thu Aug 13th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 4 days ago
Click to view the webcast

ARS Pharmaceuticals Ownership & Insider Activity

ARS Pharmaceuticals (SPRY) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 8.2% of shares outstanding. Institutional investors hold 25.0%. Over the past 90 days, insiders made 1 sale worth $34K.

Shares Outstanding

99.447M

Shares Float

68.973M

Insider Shares Owned

8.095M

Insider % Owned

8.2%

Institutional Shares Held

24.831M

Institutional % Held

25.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

1

$34K total

Net Activity

Net Selling

Net Value (90d)

-$34K

ARS Pharmaceuticals Insider Transactions (Last 6 Months)

DateInsiderTitleTypeSharesPriceValue
Jun 12, 2026Eric KarasCHIEF COMMERCIAL OFFICERSELL-OPTIONS$5.75$213K
Jun 12, 2026Alexander FitzpatrickCHIEF LEGAL OFFICERSELL3.355K$10.00$34K